Our results suggest that the D2HGDH/GSH/Prdx6/ROS axis may be involved in the development of epilepsy and that MJ33, an inhibitor of aiPLA2, could potentially reverse this phenotype. The gene discussed is PRDX6; the disease is epilepsy.